Daniel H. Geschwind, M.D., Ph.D.
University of California, Los Angeles
Dr. Daniel Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of neurology, psychiatry and human genetics at the UCLA School of Medicine. He is director of the Neurogenetics Program and the Center for Autism Research and Treatment (CART) and co-director of the Center for Neurobehavioral Genetics in the Semel Institute at UCLA. His laboratory aims to develop a mechanistic understanding of neuropsychiatric diseases, such as autism and neurodegenerative diseases, and their relationship to the range of normal human higher cognitive function and behavior. The lab’s approach relies heavily on computational and bioinformatic methods in addition to wet laboratory experimentation. The ultimate goal is to use these integrative approaches to help develop effective therapeutics for neurologic and psychiatric disorders, focusing on autism and neurodegenerative disorders. Dr. Geschwind is also a strong advocate for data and biomaterial sharing, having provided scientific oversight for the Autism Genetic Resource Exchange (AGRE). He has served on numerous scientific advisory boards, including the Faculty of 1000 Medicine, the Executive Committee of the American Neurological Association, the NIMH Advisory Council and the NIH Council of Councils. He has published over 300 papers and serves on the editorial boards of several journals including Biological Psychiatry, Cell, Human Molecular Genetics, Neurobiology of Disease, Neuron and Science. He received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2004, the Scientific Service Award from Autism Speaks in 2007, the Ruane Prize for Child and Adolescent Psychiatric Research from the Brain and Behavior foundation in 2012, the Taking on Tomorrow Innovation Award (Research/Scientific Breakthrough in Autism) - Boston Children’s Hospital in 2013 and is an elected member of the Institute of Medicine of the National Academies.